Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2016 by Agios Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Agios Pharmaceuticals, Inc. Identifier:
First received: February 21, 2014
Last updated: June 10, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2018
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)